UTHR Financial Facts

Income from continuing operations before income taxes: 239.1M
Net income per diluted common share (in dollars per share): 3.5
See Full Income Statement

Total liabilities and stockholders' equity: 2.27B
Additional paid-in capital: 1.84B
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date 2/24/17 *Est. EPS Growth Rate -1.4% *Last Qtr.
Average EPS % Beat Rate +35.4% Revenue Growth Rate +5.7% *Last Qtr.
Average % Move 1-Wk after EPS +8.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/27/16 Q316 $3.50$3.34 +$0.16$408.2M$402.35M N/A Details
7/28/16 Q216 $4.55$3.22 +$1.33$412.6M$395.15M N/A Details
4/28/16 Q116 N/A$3.21 N/A $369M$397.42M N/A N/A N/A
2/25/16 Q415 $3.68$2.55 +$1.13$404.9M$388.29M N/A Details
10/27/15 Q315 $3.55$2.35 +$1.20$386.2M$363.5M N/A Details
7/28/15 Q215 $2.55$2.31 +$0.24$347.2M$360.41M N/A Details
4/28/15 Q115 $2.55$2.14 +$0.41$327.6M$353.5M N/A Details
2/24/15 Q414 $3.21$2.03 +$1.18$346.4M$336.22M N/A Details